HAYWARD, Calif.—(BUSINESS WIRE)—Feb. 22, 2005 -- Sepragen Corporation
(Pink Sheets:SPGNA), a provider of patented technology and equipment
for purification needs in the biotech and nutraceutical industries,
today announced that it has signed a multi-year agreement with filtration
and purification industry leader, Pall Corporation (NYSE:PLL). Under
the agreement, Sepragen will develop and manufacture bench top process
development chromatography systems for Pall. The products, which
augment Pall’s extensive capabilities, will be sold and supported
by Pall’s global sales and technical support network.
Ken Frank, President of Pall BioPharmaceuticals said, “We
are very pleased with our new alliance with Sepragen, which has
a track record of developing innovative products for chromatography.
The addition of these small-scale systems to our chromatography
line expands our ability to satisfy customers’ increasing
needs for purification systems that span the drug development and
production process.” Products that scale up easily from the
lab to the manufacturing floor are one key to the industry’s
ability to bring new drugs to market quickly.
Of this arrangement, Vinit Saxena, CEO of Sepragen, had this to
say: “The Pall alliance provides validation of our technology,
position and capability. The alliance will help us significantly
enhance our revenue and, with the help of Pall’s marketing
and distribution channels, will enable us to take a greater share
in the sizeable and rapidly growing biotech market.”
About Pall Corporation
Pall Corporation is the global leader in the rapidly growing field
of filtration, separations and purification. Pall's business is
organized around two broad markets: Life Sciences and Industrial.
The Company provides leading-edge products to meet the demanding
needs of customers in biotechnology, pharmaceutical, transfusion
medicine, semiconductors, water purification, aerospace and broad
industrial markets. Total revenues are $1.8 billion. The Company
headquarters are in East Hills, New York with extensive operations
throughout the world. Visit Pall at www.pall.com.
About Sepragen
Sepragen (Pink Sheets:SPGNA) is a pioneer in bioseparations providing
innovative equipment and instruments to biotech companies and processing
know-how and technology to nutritional and dairy companies. The
Company holds over 14 patents related to its core technology.
<
Back
The statements in this release that relate to future events
or performance, statements about growth, future regulatory clearances, levels of sales and
market size and future manufacturing capacity and efficiencies are forward-looking
statements that involve risks and uncertainties, including risks associated with
uncertainties related to the development of markets for and commercial acceptance of the
company's products and services, the availability of components, competitors' product
introductions and other risks identified in the company's SEC filings. Actual results may
differ from those described in these forward-looking statements. Readers are cautioned not
to place undue reliance on these forward-looking statements, which speak only as of the
date hereof.
|
